What's New/

Latest news

ellipse bg 3
leaves bg 1
  • All
  • Advocacy
  • Experiences
  • Guest Blog
  • Information
  • Research
  • Reviews
All
  • All
  • Advocacy
  • Experiences
  • Guest Blog
  • Information
  • Research
  • Reviews
GP24 conference programme Research

GPs hear about migraine research at Wellington conference

Migraine disease was on the programme of the GP24 Conference in Wellington on 27th July. ...
Read More
Useofmedicationsformigraineresearch Research

Large unmet need for effective migraine treatment in New Zealand

Press release  Many people with migraine in New Zealand are not receiving best-practice management, according ...
Read More
PVA meeting Parliament 16July24 scaled Advocacy

Meeting with Ministers

On 16 July we met with Members of Parliament from the Labour Party in the ...
Read More
seven sharp AdvocacyInformation

Our answers to questions from Seven Sharp

Migraine featured in the media again on Monday 1 July, with an item on Seven ...
Read More
Pharmacannouncement Advocacy

What does the boost to Pharmac’s budget mean for people with migraine?

And the importance of having a charity like ours advocating for medications Migraine Foundation Aotearoa ...
Read More
migraine foudation aotearoa new zealand other types of headache 40 Advocacy

A false economy?

Press release Budget 2024 ignores over 753,000 people affected by one of Aotearoa New Zealand’s ...
Read More
new zealand health survey data a decade to be released 1 Research

Update on the number of people with migraine in New Zealand

In the absence of up-to-date national statistics on migraine in Aotearoa New Zealand, we rely ...
Read More
medsafe recommends atogepant be added to medication schedule Information

Medsafe approves atogepant for use in New Zealand

Medsafe has approved the migraine medication atogepant (Aquipta, also known as Qulipta) be added to ...
Read More
Shades for Migraine 2024 Advocacy

Shades for Migraine 2024

Shades for Migraine 2024 is fast approaching, so grab your sunnies, get creative and help ...
Read More
Migraine medications added to OFI Advocacy

Modern migraine medications added to Pharmac’s Options for Investment list

Funding of galcanezumab (Emgality), erenumab (Aimovig) and atogepant (Aquipta) progressed one step closer this week, ...
Read More
migraine foudation aotearoa new zealand our support and partners neurolocal alliance Advocacy

Our partnership with the Neurological Alliance

Migraine Foundation Aotearoa New Zealand is a member of the Neurological Alliance, a collection of ...
Read More
Patientperceptionsofbarriersresearch Research

Multiple barriers to health care for migraine disease

Press release  People with migraine disease experience similar barriers to health care as patients with ...
Read More